Influence of genetic co-factors on the population pharmacokinetic model for clopidogrel and its active thiol metabolite.

Developed model predicts that the only significant covariate influencing the observed concentrations and therefore the exposure to the active H4 metabolite is the presence of CYP2C19*2 allele.